C-Rad
38.25 SEK 0%Be the first to follow this company
C-Rad is active in medical technology. The company conducts the development, manufacturing, and sales of products and solutions in advanced radiation therapy. The business is mainly aimed at clinics that offer radiation treatment, where the company in addition to its core business offers associated installation services and support. The customers are located on a global level and the head office is located in Uppsala.
Revenue
424.6M
EBIT %
13.54 %
P/E
28.12
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
CRAD B
Daily low / high price
37.5 / 38.8
SEK
Market cap
1.29B SEK
Turnover
995.76K SEK
Volume
26K
Financial calendar
Interim report
14.05.2024
General meeting
15.05.2024
Interim report
18.07.2024
Interim report
23.10.2024
Annual report
07.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Svea Ekonomi AB | 11.9 % | 11.9 % |
Lars Kling | 7.9 % | 10.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
C-RAD Web Presentation Interim Report Q1 2024
The Nomination Committee’s revised proposal before the Annual General Meeting 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools